If you would like to be considered for the position please fill the following information out.
Breast cancer risk assessment has become a crucial tool in modern breast screening programs, and the demand for it is steadily rising. While the increased awareness
The rapid advancement of breast cancer screening and prevention technology is cause for excitement and hope in our industry, with AI breast cancer risk assessment quickly moving to the forefront.
Integrated AI, genetic, and imaging solutions from Clairity, Myriad, and MagView help identify high-risk women and enable earlier breast cancer intervention.
